House member introduces bill to sanction China over synthetic drug production
/ 1 min read
Table of Contents
A member of the U.S. House of Representatives introduced a bill titled “To authorize sanctions relating to the production and distribution of illicit synthetic narcotics by the People’s Republic of China.” The bill was referred to the Committee on Foreign Affairs. It was also sent to the Committees on Financial Services, Oversight and Government Reform, and the Judiciary for review.
Why it matters: This action is procedural. It places a proposed piece of legislation into the queue for committee review. It does not change current law, impose any new penalties, or alter existing trade or diplomatic policies. The practical significance is limited to the legislative calendar and the potential for future debate if the committees advance the bill.
Who it affects
- Members of the House Committee on Foreign Affairs
The source is Congress.gov, the official legislative database for the U.S. Congress, and readers should check the full text of the bill for specific details not included in the referral notice.
Agency: House
Source: Congress.gov — read the official document